AI Summary
- Mobile application-enabled lifestyle interventions produce modest but significant reductions in body weight and hepatic steatosis markers in patients with MAFLD.
- Digital programmes improve adherence to diet and physical activity, enhancing metabolic outcomes and patient engagement compared with usual care.
- Evidence is limited by small trials, heterogeneity and short follow-up, requiring larger, long-term randomised studies to confirm clinical benefit and cost-effectiveness.
BMJ Open Gastroenterol. 2026 Oct 27;13(1):e002514. doi: 10.1136/bmjgast-2026-002514.
NO ABSTRACT
PMID:42946487 | DOI:10.1136/bmjgast-2026-002514
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
Save as PDF
⭐ My Revision List

